Covid-19: More trials needed to show mortality reduction with Itolizumab and Tocilizumab, says ICMR

7.28 am: Moderna Covid-19 vaccine enters final stage, reports Bloomberg. The US company will start final-phase trials on 30,000 people on...

7.28 am: Moderna Covid-19 vaccine enters final stage, reports Bloomberg. The US company will start final-phase trials on 30,000 people on July 27.

Also read

When a Covid-19 vaccine is discovered, will it be freely available and be affordable to all?

7.25 am: The Donald Trump administration rescinds order denying foreign students US visas, says judge.

7.24 am: Mizoram reports five new cases, taking the total number in the state to 238, says Chief Minister Zoramthanga.

7.21 am: Assam’s tally crosses 18,000-mark with 859 new cases and six deaths, says Health Minister Himanta Biswa Sarma.

📌Alert ~ 859 new #COVID19 ve+ patients in Assam, 627 in Guwahati alone.

Take care & precautions.

↗️Total cases 18666
↗️Recovered 12173
↗️Active cases 6444
↗️Deaths 46

11:50 PM/July 14/ Day's total 859#AssamCovidCount pic.twitter.com/m9286wJTRa

— Himanta Biswa Sarma (@himantabiswa) July 14, 2020

7.17 am: Indian Council of Medical Research Director-General Dr Balram Bhargava says neither Itolizumab and Tocilizumab drug had demonstrated reduction in mortality among Covid-19 patients, reports News18. Bhargava adds that more trials are needed.

7.10 am: Here are the top updates from Tuesday

• India reported 28,498 new coronavirus cases on Tuesday, taking the total to 9,06,752. The toll rose by 553 to 23,727. More than 5.71 lakh people have recovered. The Union health ministry said that recovery rate in 20 states is more than national average of 63%. Of these states, Uttar Pradesh has a recovery rate of 64%, Odisha 67%, Assam 65%, Gujarat 70%,...

  Read more